cyclopentane has been researched along with apomorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andén, NE; Bédard, P | 1 |
| Altemus, KL; Cepeda, C; Colwell, CS; Levine, MS | 1 |
| Assié, MB; Auclair, A; Bardin, L; Consul-Denjean, N; Depoortère, R; Newman-Tancredi, A; Sautel, F | 1 |
3 other study(ies) available for cyclopentane and apomorphine
| Article | Year |
|---|---|
Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
Topics: Animals; Apomorphine; Atropine; Basal Ganglia; Brain; Catalepsy; Cyclopentanes; Dopamine; Hallucinogens; Haloperidol; Humans; Mandelic Acids; Norepinephrine; Parasympatholytics; Piperidines; Rats; Scopolamine; Trihexyphenidyl | 1971 |
Regulation of N-methyl-D-aspartate-induced toxicity in the neostriatum: a role for metabotropic glutamate receptors?
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apomorphine; Cyclopentanes; GABA Agonists; Hippocampus; In Vitro Techniques; Kainic Acid; Male; Microscopy, Video; Motor Activity; N-Methylaspartate; Neostriatum; Neurotoxins; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reference Values | 1996 |
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzofurans; Benzylamines; Cyclopentanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Receptors, Dopamine D3; Receptors, Dopamine D4; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2007 |